BioStem Technologies Inc. to Present at The MicroCap Conference on October 1st and 2nd in New York City at the Essex House
Pompano Beach, FL, Sept. 19, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with a concentration in Pharmaceuticals and Regenerative Medicine, will be presenting at this year’s MicroCap Conference on October 1st and 2nd in New York City.
The MicroCap Conference is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most attractive small companies, learn from various expert panels, and mingle with other microcap investors.
The MicroCap Conference will take place in New York City at the Essex House on October 1st and 2nd. Registration will begin on Monday at 7:00AM and will last until the evening. These days will be jam-packed with company presentations, 1-on-1 meetings, roundtables, expert panel discussions, and plenty of time to network with other investors.
About BioStem Technologies, Inc. (OTC PINK: BSEM): BioStem Technologies, Inc. is a global life sciences corporation, providing innovative technologies with a concentration in Pharmaceuticals and Regenerative Medicine. The Company’s mission is to discover, develop and produce the most effective Pharmaceutical and Regenerative Medicine products in the world. The Company is comprised of a diverse group of scientists, physicians, and entrepreneurs who collaborate to create innovative products. These technologies improve the Quality of Life for our patients and, as a result, drive shareholder value.
REGISTRATION FOR INVESTORS
To request free registration, please go to our website ( www.microcapconf.com ), and click the “Registration” button.
For our most updated list of companies, please go to our website ( www.microcapconf.com )
# Maxim Group # The Special Equities Group
# Interactive Offers # M2 Compliance
# MZ Group # Irth Communications # Gillon Tax Advisors # Proactive Investors # Hunter Taubman Fischer & LI LLC # Equities.com # Issuer Direct # The Money Channel # Marcum # Equisolve # PCG Advisory Group # CoreIR # Berg Capital Markets, LLC
News Compliments of ACCESSWIRE
FOR MORE INFORMATION
Please visit: www.microcapconf.com
Or, contact Ashley Allard, at firstname.lastname@example.org
Forward-Looking Statements: Except for statements of historical fact, the matters discussed in this press release are forward looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “future,” “plan” or “planned,” “expects,” believe” or “projected.” These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company’s control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing, exploiting and protecting proprietary technologies, intense competition and additional risks factors as discussed in reports filed by the company with OTC Markets.
BioStem Technologies, Inc. Phone: 954-380-8342 Website: http://www.biostemtech.com Email: email@example.com Twitter: @Biostemtech Facebook: BioStem Technologies Investor Relations: Andrew Van Vurst firstname.lastname@example.org (954) 380-8342